Zoetis exceeded market expectations in Q4 2024, with impressive financial performance despite challenges in specific segments ...
Biopharmaceutical firm Axsome Therapeutics (NASDAQ:AXSM) reported mixed fourth-quarter and full-year 2024 earnings on Tuesday, Feb. 18. The company achieved substantial revenue growth, with sales ...
Leonardo SpA (FINMF) reports robust growth in orders, revenue, and cash flow, while addressing challenges in Aerostructures ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback